CIK 0001429260
- Non-accelerated filer
- Smaller reporting company
Fortress Biotech, Inc.
Sign in to watch- Ticker
- FBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205157386
- Phone
- +1 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Former names
- Fortress Biotech, Inc., CORONADO BIOSCIENCES INC
Securities
- FBIO Common Stock Nasdaq
- FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 47 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-09-09 | Avgerinos George SVP, Biologics Operations | Returned to the company | −14,100 | $2.62 | $37K | 212,036 |
| 2015-09-08 | Avgerinos George SVP, Biologics Operations | Returned to the company | −11,704 | $2.57 | $30K | 226,136 |
| 2015-09-04 | Avgerinos George SVP, Biologics Operations | Returned to the company | −2,136 | $2.60 | $6K | 237,840 |
| 2015-09-03 | Avgerinos George SVP, Biologics Operations | Returned to the company | −18,200 | $2.58 | $47K | 239,976 |
| 2015-09-02 | Avgerinos George SVP, Biologics Operations | Returned to the company | −24,900 | $2.60 | $65K | 258,176 |
| 2015-09-01 | Avgerinos George SVP, Biologics Operations | Returned to the company | −158 | $2.70 | $427 | 283,076 |
| 2015-08-31 | Avgerinos George SVP, Biologics Operations | Returned to the company | −3,500 | $2.94 | $10K | 283,234 |
| 2015-08-21 | Avgerinos George SVP, Biologics Operations | Returned to the company | −10,000 | $2.55 | $25K | 286,734 |
| 2015-08-19 | Avgerinos George SVP, Biologics Operations | Returned to the company | −11,266 | $3.00 | $34K | 296,734 |
| 2015-08-13 | Avgerinos George SVP, Biologics Operations | Grant or award | +300,000 | 308,000 | ||
| 2015-07-15 | Avgerinos George SVP, Biologics Operations | Returned to the company · Options to purchase Common Stock | −200,000 | $3.53 | $706K | 0 |
| 2015-07-15 | Klein Dov Director | Grant or award | +50,000 | 55,000 | ||
| 2015-06-01 | ROSENWALD LINDSAY A MD President and CEO | Purchase | +785 | $1.80 | $1K | 4,792,106 |
| 2015-03-12 | LOBELL J JAY Director | Grant or award | +50,000 | 436,000 | ||
| 2015-03-12 | LOBELL J JAY Director | Grant or award | +50,000 | 486,000 | ||
| 2015-03-12 | Rowinsky Eric K Director | Grant or award | +50,000 | 100,000 | ||
| 2015-03-12 | Rowinsky Eric K Director | Grant or award | +50,000 | 150,000 | ||
| 2014-12-01 | ROSENWALD LINDSAY A MD President and CEO | Purchase | +974 | $1.45 | $1K | 4,791,321 |
| 2014-12-01 | Lu Lucy Chief Financial Officer | Purchase | +5,000 | $1.45 | $7K | 35,631 |
| 2014-11-06 | WEISS MICHAEL S Exec. VC - Strategic Dev. | Purchase | +1,000,000 | $1.61 | $1.6M | 6,938,038 |
Page 10 of 12 · 231 trades